Researcher
Steven De Vleeschouwer
- Disciplines:Biomechanics, Morphological sciences, Neurosciences, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Responsible
From1 Jan 2013 → Today - Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Member
From1 Aug 2001 → Today
Projects
1 - 10 of 22
- Molecular Brain Tumor DetectorFrom1 Feb 2024 → TodayFunding: Other EU initiatives out of framework
- The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomicsFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- Immunotherapy for childhood, adolescent, and adult Glioblastoma: towards tumour-immune interactions driven precision medicine using spatially resolved radio-multiomics.From15 Jan 2023 → TodayFunding: BOF - various
- Investigating the role of astrocytes and noradrenaline as critical regulators of neuronal circuit excitability.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- De evidentie rond het coiling-clipping paradigma in de behandeling van cerebrale aneurysmata uitdagen en in kaart brengen door middel van multimodale stratificatie.From8 Dec 2021 → TodayFunding: FWO Strategic Basic Research Grant
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- Evaluating the Role of Autophagy in the Tumor Vasculature and as Anti-angiogenic Escape MechanismFrom1 Oct 2020 → 30 Sep 2021Funding: BOF - postdoctoral mandates
- Opening the brain blood barrier to treat brain tumoursFrom1 Jan 2020 → 31 Dec 2022Funding: H2020 - European Institute of Innovation and Technology, Horizon Europe - European Institute of Innovation and Technology (EIT)
- Screening of Hyp-PDT induced ICD-sensitive GBM Immunophenotype and Exploration of Synergetic Effect of Sonodynamic Therapy in GBM ImmunotherapyFrom2 Dec 2019 → 2 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Visual prostheses based on high resolution brain stimulationFrom1 Oct 2019 → 30 Sep 2023Funding: BOF - projects
Publications
31 - 40 of 141
- The incidence of postoperative cerebrospinal fluid leakage after elective cranial surgery: a systematic review (Sept, 10.1007/s10143-021-01641-y, 2021)(2022)
Authors: Birgit Coucke, Laura Van Gerven, Steven De Vleeschouwer, Frank Van Calenbergh, Johan van Loon, Tom Theys
Pages: 2501 - 2501 - Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey(2022)
Authors: Steven De Vleeschouwer
Pages: 365 - 376 - Towards real-time intraoperative tissue interrogation for REIMS-guided glioma surgery(2022)
Authors: Laura Van Hese, Steven De Vleeschouwer, Tom Theys, Lien Solie, Raf Sciot, Steffen Rex, Eva Cuypers
Pages: 80 - 89 - Global comparison of awake and asleep mapping procedures in glioma surgery: An international multicenter survey(2022)
Authors: Steven De Vleeschouwer
Pages: 123 - 132 - Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma(2022)
Authors: Frederik De Smet, Abhishek Garg, Patrizia Agostinis, Steven De Vleeschouwer
Pages: 1 - 11 - Decision making and surgical modality selection in glioblastoma patients: an international multicenter survey(2022)
Authors: Steven De Vleeschouwer
Pages: 465 - 482 - Treatment of ruptured subclavian steal flow-related vertebrobasilar junction aneurysms: Case report on surgical and endovascular considerations from two cases(2022)
Authors: Geert Maleux, Kim Daenens, Johan van Loon, Steven De Vleeschouwer
- SINGLE-CELL DRUG ACTIVITY MAPPING IN GLIOBLASTOMA IDENTIFIES EXTENDED DRUG RESPONSE HETEROGENEITY AND THERAPY-INDUCED CELLULAR PLASTICITY(2021)
Authors: Dena Panovska, Raf Sciot, Paul Clement, Frederic Rousseau, Joost Schymkowitz, Steven De Vleeschouwer, Frederik De Smet
Pages: 167 - 167 - SPATIAL MAPPING OF THERAPY-INDUCED, PATHOLOGICAL CHANGES IN GLIOBLASTOMA AT SINGLE-CELL RESOLUTION(2021)
Authors: Maxime Vanmechelen, Sien Bevers, Julie Messiaen, Yannick Van Herck, Francesca Bosisio, Steven De Vleeschouwer, Paul Clement, Raf Sciot, Frederik De Smet
Pages: 119 - 119 - DIFFERENTIAL DRUG SENSITIVITY ANALYSIS IN PAIRED PATIENT-DERIVED CELL LINES OF GLIOBLASTOMA(2021)
Authors: Dena Panovska, Bart De Moor, Paul Clement, Steven De Vleeschouwer, Raf Sciot, Frederik De Smet
Pages: 220 - 220
Patents
1 - 3 of 3
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)